Wuhu Snnda Medical Treatment Appliance Technology Co., Ltd

2006: Approved for use nationally by the China FDA.

2008: CE Mark and ISO 13485.

2009: Several pilot studies and randomized clinical trials (RCTs) of ShangRing in Africa.

2012: United States FDA (501K) gave clearance for ShangRing.

2012: World Health Organization (WHO) initiated reviews from five RCTs and clinical studies of ShangRing use in three African countries (Kenya, Zambia and Uganda).

2013: Independent experts from a WHO Technical Advisory Group (TAG) reported over 99% of the circumcisions using ShangRing in the African studies were safely and effectively performed with no serious adverse events (AEs).1

2015: ShangRing received WHO Pre-Qualification for use.

2019: Cooperated with USAID and Global fund

2020: MDSAP certificate

Wuhu Snnda Medical Treatment Appliance Technology Co., Ltd, founded in June 2005 by Mr Shang Jianzhong, is a science and technology innovation-oriented enterprise and headquartered at the Service Center for Science & Technology Innovation in Wuhu Economic & Technological Development Zone. As one of the global partners of Bill & Melinda Gates Foundation, Wuhu Snnda is a leading business in the field of HIV/ AIDS prevention by using male circumcision devices, and has been qualified for China GMP, US FDA and ISO 13485. The ShangRing® male circumcision device received series of prizes in the past years, including the First Prize for Technical Achievement in 2013 (American Society for Reproductive Medicine), Wuhu Municipal Science & Technology Contribution Award in 2014, the Gold Medal for Inventions in Geneva in 2015, Gold Medal for Invention (ShangRing disposable circumcision device) in 2016 in Nuremberg, Germany, award of Anhui Provincial High-tech Business and Excellent Chinese Patent in 2016, Gold Medal in recognition of innovative excellence in the category of Engineering, Award of Merit, and Humanitarian Award in 2017 (Pittsburgh, PA, USA). Particularly, Mr. Shang Jianzhong is the first Chinese winner of Humanitarian Award in the history of international INPEX.

The ShangRing® male circumcision device, developed and manufactured by Wuhu Snnda, is the first China-made device prequalified by World Health Organization, and for the first time fully makes male circumcision without any suturing, for which is recognized as the revolution in the history of global male circumcision.

Wuhu Snnda is committed to the mission that 'science and technology can create value and cooperation bring about win-win', and determined to make ShangRing® devices available both at home and abroad so that we can extend greater contribution to the reproductive health of the human race.

ShangRingTM Male Circumcision Device (Self-locking)

Used for male circumcision in Urology for infant，adolescent and adult males, specifically: ages ≥13 years with the flip technique or the no-flip technique, and ages 10 – 12 years only with the no-flip technique.

ISO 13485: 2016

CE

FDA 510(K)

WHO List of PQMC

MDSAP certificate

International Patent No.: PCT/CN2006 002178